Unió Europea - estonià - EMA (European Medicines Agency)

pharmsure veterinary products europe ltd - mycoplasma synoviae tüvi ms-h - immunoloogilised ravimid jaoks linnud, live bacterial vaccines - kana - aktiivse immuniseerimise tulevikus broiler kanade aretaja, tulevikus kiht kasvataja kanad ja tulevikus kiht kanad, et vähendada õhu-sac kahjustused ja vähendada munade arv ebanormaalne shell moodustamine põhjustatud mycoplasma synoviae.

Unió Europea - estonià - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - sead - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Unió Europea - estonià - EMA (European Medicines Agency)

intervet international b.v. - sead circovirus tüüp 2 (pcv2) orf2 allüksuste antigeeni, mycoplasma hyopneumoniae j inaktiveeritud tüvi - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - sead (nuumamiseks) - aktiivse immuniseerimise sigade vähendada viraemia, viirus koormus (kopsud ja lümfoidse koe, viiruse levikuga põhjustatud sigade circovirus tüüp 2 (pcv2) infektsiooni ja raskuse kopsu kahjustused põhjustavad mycoplasma hyopneumoniae infektsioon. et vähendada mycoplasma hyopneumoniae ja / või pcv2 infektsioonide ilmnemist viimistlusperioodi jooksul (nagu on täheldatud välitingimustes).

Estònia - estonià - Ravimiamet

zoetis belgium - mükoplasma+haemophilus parasuis, inaktiveeritud - süstesuspensioon - 1annus 25annus 1tk; 1annus 25annus 10tk; 1annus 125annus 1tk; 1annus 50annus 10tk; 1annus 10annus 10tk

Estònia - estonià - Ravimiamet

intervet international b.v. - mükoplasma - suspensiooni lüofilisaat - 1annus 2000annus 10tk; 1annus 1000annus 1tk; 1annus 2000annus 1tk; 1annus 1000annus 10tk

Estònia - estonià - Ravimiamet

elanco gmbh - mükoplasma - süsteemulsioon - 1annus 50annus 1tk; 1annus 50annus 10tk

Estònia - estonià - Ravimiamet

intervet international b.v. - mükoplasma - süstesuspensioon - 2ml 20ml 1tk; 2ml 50ml 1tk; 2ml 100ml 1tk; 2ml 200ml 10tk; 2ml 200ml 5tk; 2ml 200ml 1tk

Estònia - estonià - Ravimiamet

intervet international b.v. - mükoplasma - süsteemulsioon - 1ml 50ml 2tk; 1ml 100ml 10tk; 1ml 200ml 2tk; 1ml 50ml 10tk; 1ml 100ml 5tk

Estònia - estonià - Ravimiamet

boehringer ingelheim vetmedica gmbh - mükoplasma - süstesuspensioon - 1annus 10annus 12tk; 1annus 50annus 1tk; 1annus 100annus 12tk; 1annus 250annus 1tk; 1annus 100annus 1tk

Estònia - estonià - Ravimiamet

intervet international b.v. - mükoplasma - süsteemulsioon - 1annus 0.2ml 20ml 10tk; 1annus 0.2ml 20ml 5tk; 1annus 0.2ml 5ml 1tk; 1annus 0.2ml 10ml 5tk; 1annus 0.2ml 10ml 1tk